News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Palasis Maria
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/12/2023 |
4/A
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 150,000 options
@ $2.99, valued at
$448.5k
|
|
| 02/02/2023 |
4
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 250,000 options
@ $2.85, valued at
$712.5k
|
|
| 02/18/2022 |
4
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 175,000 options
@ $4.21, valued at
$736.8k
|
|
| 02/15/2022 |
4
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 127,400 options
@ $4.78, valued at
$609k
|
|
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2020 |
4
| Palasis Maria (President & CEO) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 326,303 options
@ $16, valued at
$5.2M
|
|
| 04/30/2020 |
3
| Palasis Maria (President & CEO) has filed a Form 3 on Lyra Therapeutics, Inc. |
|
|